{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:41:55Z","timestamp":1764790915795,"version":"3.46.0"},"reference-count":36,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The College of American Pathologists periodically surveys laboratories to determine changes in cytopathology practices. We report the results of a 2011 gynecologic cytology survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To provide a cross-sectional survey of gynecologic cytology practices in 2010.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>In 2011, a survey was sent to 1604 laboratories participating in the College of American Pathologists gynecologic cytology interlaboratory comparison education program and proficiency testing programs requesting data from 2010 on the following topics: terminology\/reporting, cytotechnologist workload, quality assurance, reagents, and ancillary testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six hundred and twenty-five laboratories (39%) replied to the survey. The nonstandard use of \u201clow-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion\u201d is used by most laboratories to report the presence of low-grade squamous intraepithelial lesion with possibility of high-grade squamous intraepithelial lesion. Most laboratories also report the presence or absence of cells from the transformation zone. Most respondents do not limit cytotechnologist screening workload during the work shift. Only about one-third of laboratories (188 of 582; 32%) use image-assisted screening devices. Rapid prescreening as a quality assurance measure is used by only 3.5% (21 of 594) of the laboratories. When used for screening, most laboratories use the imager for retrospective review of slides to detect human locator and interpretive errors. Most laboratories receive both liquid-based cytology samples (mainly ThinPrep, Hologic, Marlborough, Massachusetts) and conventional Papanicolaou tests. Expiration dates of liquid-based cytology test vials are not usually recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The field of gynecologic cytology is evolving rapidly. These survey results offer a snapshot of national gynecologic cytology practices in 2010.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2015-0004-cp","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T09:48:12Z","timestamp":1433497692000},"page":"13-21","source":"Crossref","is-referenced-by-count":8,"title":["Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire"],"prefix":"10.5858","volume":"140","author":[{"given":"Barbara A.","family":"Crothers","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Area Laboratory Services, Walter Reed National Military Medical Center, Bethesda, Maryland (Dr Crothers); the Pathology Cytology Laboratory, Mount Zion Medical Center, University of California, San Francisco (Dr Darragh); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Tambouret and Wilbur); the Department of Cytopathology, Northwester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa M.","family":"Darragh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary H.","family":"Tambouret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritu","family":"Nayar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guliz A.","family":"Barkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine Noga","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayalakshmi","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. Laura","family":"Tabatabai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhona J.","family":"Souers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Wilbur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann T.","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2015,6,5]]},"reference":[{"issue":"1","key":"2020081300231060400_i1543-2165-140-1-13-b01","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/LGT.0b013e3181ed3d6d","article-title":"Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment","volume":"15","author":"Burks","year":"2011","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"2020081300231060400_i1543-2165-140-1-13-b02","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1067\/mob.2003.461","article-title":"ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy","volume":"188","author":"Cox","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2020081300231060400_i1543-2165-140-1-13-b03","first-page":"523","article-title":"Cervical biopsy-cytology correlation: a College of American Pathologists Q-Probes study of 22\u2009439 correlations in 348 laboratories","volume":"120","author":"Jones","year":"1996","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"2020081300231060400_i1543-2165-140-1-13-b04","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/AOG.0b013e3181834637","article-title":"Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology","volume":"112","author":"Castle","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2020081300231060400_i1543-2165-140-1-13-b05","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cncr.21664","article-title":"Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes","volume":"106","author":"Evans","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"2020081300231060400_i1543-2165-140-1-13-b06","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2012.02.017","article-title":"The \u201csee and treat\u201d strategy for identifying cytologic high-grade precancerous cervical lesions among low-income Brazilian women","volume":"118","author":"Nogara","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"2020081300231060400_i1543-2165-140-1-13-b07","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/cncr.11721","article-title":"The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion","volume":"99","author":"Nasser","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"2020081300231060400_i1543-2165-140-1-13-b08","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cncr.22169","article-title":"The significance of \u201clow-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion\u201d as a distinct squamous abnormality category in Papanicolaou tests","volume":"108","author":"Elsheikh","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"2020081300231060400_i1543-2165-140-1-13-b09","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1309\/QRDNMWWAKJQTVJGF","article-title":"\u201cLow-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion\u201d is a distinct cytologic category: histologic outcomes and HPV prevalence","volume":"128","author":"Owens","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"2020081300231060400_i1543-2165-140-1-13-b10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-6413-4-7","article-title":"Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category?: a study on SurePath specimens with review of literature","volume":"4","author":"Shidham","year":"2007","journal-title":"Cytojournal"},{"issue":"1","key":"2020081300231060400_i1543-2165-140-1-13-b11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2010.12.004","article-title":"Clinical importance of \u201clow-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)\u201d terminology for cervical smears: 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature","volume":"121","author":"Ince","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2020081300231060400_i1543-2165-140-1-13-b12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cncy.21210","article-title":"Should LSIL-H be a distinct cytology category?: a study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women","volume":"120","author":"Zhou","year":"2012","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"2020081300231060400_i1543-2165-140-1-13-b13","first-page":"S1","article-title":"ASCCP Consensus Guidelines Conference. 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"2020081300231060400_i1543-2165-140-1-13-b14","first-page":"172","article-title":"Squamous cell tumours and precursors","author":"Stoler","year":"2014","journal-title":"WHO Classification of Tumours of Female Reproductive Organs. 4th ed"},{"key":"2020081300231060400_i1543-2165-140-1-13-b15","doi-asserted-by":"crossref","unstructured":"Solomon D, Nayar R, eds. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. 2nd ed. New York, NY: Springer-Verlag;2004.","DOI":"10.1007\/978-1-4612-2042-8"},{"issue":"6","key":"2020081300231060400_i1543-2165-140-1-13-b16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1309\/AJCPTYDD9G2NCUMF","article-title":"Increasing cytotechnologist workload above 100 slides per day using the BD FocalPoint GS Imaging System negatively affects screening performance","volume":"138","author":"Levi","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2020081300231060400_i1543-2165-140-1-13-b17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cncy.20065","article-title":"Increasing cytotechnologist workload above 100 slides per day using the ThinPrep imaging system leads to significant reductions in screening accuracy","volume":"118","author":"Elsheikh","year":"2010","journal-title":"Cancer Cytopathol"},{"issue":"11","key":"2020081300231060400_i1543-2165-140-1-13-b18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/dc.21541","article-title":"Predicting screening sensitivity from workload in gynecologic cytology: a review","volume":"39","author":"Renshaw","year":"2011","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"2020081300231060400_i1543-2165-140-1-13-b19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/dc.21495","article-title":"Individual estimated sensitivity and workload for manual screening of SurePath gynecologic cytology","volume":"40","author":"Ellis K, Renshaw AA, Dudding N","year":"2012","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"2020081300231060400_i1543-2165-140-1-13-b20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cncy.20060","article-title":"Does the time of day or weekday affect screening accuracy?: a pilot correlation study with cytotechnologist workload and abnormal rate detection using the ThinPrep Imaging System","volume":"118","author":"Elsheikh","year":"2010","journal-title":"Cancer Cytopathol"},{"journal-title":"Medical Device-Tips and Articles on Device Safety resources Web page","article-title":"How laboratories can safely calculate workload for FDA-approved semi-automated gynecologic cytology screening devices","author":"US Food and Drug Administration","key":"2020081300231060400_i1543-2165-140-1-13-b21"},{"journal-title":"FDA premarket approval for the ThinPrep Imaging System. FDA\/CEDR resources Web page","article-title":"Summary of safety and effectiveness data","author":"US Food and Drug Administration","key":"2020081300231060400_i1543-2165-140-1-13-b22"},{"journal-title":"FDA premarket approval for the BD FocalPoint GS Imaging System. FDA\/CEDR resources Web page","article-title":"Summary of safety and effectiveness data","author":"US Food and Drug Administration","key":"2020081300231060400_i1543-2165-140-1-13-b23"},{"issue":"40","key":"2020081300231060400_i1543-2165-140-1-13-b24","first-page":"7146","article-title":"Clinical Laboratory Improvement Amendments of 1998\u2014standard: cytology: final rule","volume":"57","author":"Department of Health and Human Services, Health Care Financing Administration","year":"1992","journal-title":"Fed Regist"},{"issue":"1","key":"2020081300231060400_i1543-2165-140-1-13-b25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.21424","article-title":"Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy","volume":"108","author":"Djemli","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"2020081300231060400_i1543-2165-140-1-13-b26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000325307","article-title":"Comparison of false negative rates between 100% rapid review and 10% random full rescreening as internal quality control methods in cervical cytology screening","volume":"53","author":"Lee","year":"2009","journal-title":"Acta Cytol"},{"issue":"3","key":"2020081300231060400_i1543-2165-140-1-13-b27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/dc.21167","article-title":"ASC\/SIL ratio for cytotechnologists: a survey of its utility in clinical practice","volume":"38","author":"Renshaw","year":"2010","journal-title":"Diagn Cytopathol"},{"journal-title":"CAP Reference, Resources and Publications Web page","article-title":"Master All Common Checklist: CAP Accreditation Program","author":"College of American Pathologists","key":"2020081300231060400_i1543-2165-140-1-13-b28"},{"issue":"40","key":"2020081300231060400_i1543-2165-140-1-13-b29","first-page":"7146","article-title":"Clinical Laboratory Improvement Amendments of 1998\u2014standard: test systems, equipment, instruments, reagents, materials, and supplies: final rule","volume":"57","author":"Department of Health and Human Services, Health Care Financing Administration","year":"1992","journal-title":"Fed Regist"},{"key":"2020081300231060400_i1543-2165-140-1-13-b30","unstructured":"ThinPrep 2000 System [product insert]. Marlborough, MA: Hologic, Inc; 2011."},{"key":"2020081300231060400_i1543-2165-140-1-13-b31","unstructured":"SurePath Collection [product insert]. Burlington, NC: TriPath Imaging, Inc; 2011."},{"issue":"4","key":"2020081300231060400_i1543-2165-140-1-13-b32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2303.2009.00661.x","article-title":"High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage","volume":"20","author":"Hardie","year":"2009","journal-title":"Cytopathology"},{"issue":"1","key":"2020081300231060400_i1543-2165-140-1-13-b33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcv.2010.02.010","article-title":"Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) test","volume":"48","author":"Dixon","year":"2010","journal-title":"J Clin Virol"},{"issue":"2","key":"2020081300231060400_i1543-2165-140-1-13-b34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cncr.11058","article-title":"Stability of archived liquid-based cervical cytologic specimens","volume":"99","author":"Castle","year":"2003","journal-title":"Cancer"},{"issue":"2","key":"2020081300231060400_i1543-2165-140-1-13-b35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jviromet.2007.09.014","article-title":"Recovery of DNA for the detection and genotyping of human papillomavirus from clinical cervical specimens stored for up to 2 years in a universal collection medium with denaturing reagent","volume":"147","author":"Campos","year":"2008","journal-title":"J Virol Methods"},{"issue":"4","key":"2020081300231060400_i1543-2165-140-1-13-b36","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62341-3","article-title":"Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer","volume":"166","author":"Heselmeyer-Haddad","year":"2005","journal-title":"Am J Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/140\/1\/13\/2358990\/arpa_2015-0004-cp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/140\/1\/13\/2358990\/arpa_2015-0004-cp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:34:36Z","timestamp":1764790476000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/140\/1\/article-p13.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,6,5]]},"published-print":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2015-0004-cp","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"type":"electronic","value":"1543-2165"},{"type":"print","value":"0003-9985"}],"subject":[],"published":{"date-parts":[[2015,6,5]]}}}